Phase III Clinical Trial Shows Improved Outcomes for Laboratorians
ClinicalLabAdvisor.com announced positive results today from their Phase 3 clinical trial, which evaluated the efficacy of on-demand expertise against placebo for empowering better and faster clinical laboratory decisions.
The trial achieved its primary endpoint, showing improved median decision-making time (95% CI) and significantly fewer errors than the control group. Laboratorians treated with on-demand expertise reported sensations of exhilaration and astonishment.
Decision Fatigue (DF) is a serious and sometimes debilitating chronic condition. The tested patient population: laboratorians facing intense professional demands, has had limited therapeutic options for DF until today. “We are proud to be bringing this important solution to those who need it most,” said the Clinical Lab Advisor spokesperson.
The randomized, double-blind, placebo-controlled “SMART” study demonstrated unequivocally that getting advice from people who actually know what they’re doing improves outcomes.
“The duration of treatment depends upon the clinical needs of the patient. A high correlation was observed between getting advice from qualified specialists and better decision-making, which ultimately led to lower costs as well.” said the company’s CMO.
Before consuming on-demand expertise, it’s important to consult with a physician.
On-demand expertise may contain new ideas and should not be taken by laboratorians who are known to be allergic to fresh perspectives. Some laboratorians consuming on-demand expertise reported high levels of elation and redness of the eyes after, “happy crying.”
Animal studies suggest that on-demand expertise may cause severe euphoria and render one incapable of operating heavy equipment. Adverse drug reactions (ADRs) have also been observed in middle eastern goats.
For more information about on-demand help and advice from world-class lab professionals, visit Clinicallabadvisor.com.